Introduction of New Therapies Affects Pregnancy Rates in Women With CF, Study Reports
The overall rate at which women with cystic fibrosis are becoming pregnant dropped slightly in recent years — coinciding with the...
2nd Middle East Cystic Fibrosis Conference
Time is running out to take advantage of early registration discounts for the upcoming MECFC 2018 taking place in Izmir, Turkey in March....
Cancer gene plays key role in cystic fibrosis lung infections
PTEN is best known as a tumor suppressor, a type of protein that protects cells from growing uncontrollably and becoming cancerous. But...
Why Aspiration Is a Silent, Hidden Danger for Cystic Fibrosis Patients
Dr. Gwen A. Huitt is an infectious disease doctor at National Jewish Health with a special interest in mycobacteria, bronchiectasis, and...
Protein structure could unlock new treatments for cystic fibrosis
Cystic fibrosis is a severe hereditary disease of the lung, for which there is currently no cure. The underlying cause of the disease is...
Proteostasis’ CFTR Modulators Show Potential in Improving Effectiveness of Orkambi
Clinical trials on all three Proteostasis Therapeutics’ investigational cystic fibrosis modulators — PTI-428, PTI-801, and PTI-808 — have...
Scientists Explore New Way to Generate Stem Cell-like Cells for CF Therapy
Canadian researchers developed a safer and more cost-effective method for transforming differentiated adult cells into stem-like cells, a...
Oral therapy as safe, effective as insulin in cystic fibrosis-related diabetes
Patients with cystic fibrosis-related diabetes treated with oral repaglinide for 24 months experienced improvements in HbA1c and...
Garlic Compound Could Kill Superbugs
Garlic can do more than ward off vampires. It appears an active sulphurous compound, called ajoene, in the allium can help fight...
Kalydeco Seen as Safe in Treating Young Children, Ages 1 to 2, in Phase 3 Trial, Vertex Reports
Kalydeco (ivacaftor) is safe and effective in 1- and 2-year-olds with cystic fibrosis (CF), Vertex Pharmaceuticals reported based on data...
